StonvexLoading…
StonvexStonvexStonvexCore line items from URI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $4.26B | $929.00M | $3.69B | $2.70B | $1.76B |
Operating Income | Not available | $869.00M | $3.97B | $1.11B | $1.00B |
Net Income | Not available | $531.00M | $2.49B | $701.00M | $622.00M |
EPS (Diluted) | $11.65 | $8.43 | $38.61 | $10.91 | $9.59 |
Total Assets | Not available | $29.89B | $29.87B | $30.07B | $29.21B |
Total Liabilities | Not available | $20.92B | $20.90B | $21.07B | $20.17B |
Cash & Equivalents | Not available | $156.00M | $459.00M | $512.00M | $548.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 62.73M | 63.10M | 63.77M | 64.45M |